[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Malaria Drugs Market Growth 2024-2030

May 2024 | 115 pages | ID: G81FA43AB76EEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

The global Malaria Drugs market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Malaria Drugs Industry Forecast” looks at past sales and reviews total world Malaria Drugs sales in 2023, providing a comprehensive analysis by region and market sector of projected Malaria Drugs sales for 2024 through 2030. With Malaria Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Malaria Drugs industry.

This Insight Report provides a comprehensive analysis of the global Malaria Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Malaria Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Malaria Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Malaria Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Malaria Drugs.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report presents a comprehensive overview, market shares, and growth opportunities of Malaria Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type
  • Aryl Aminoalcohol Compounds
  • Antifolate Compounds
  • Artemisinin Compounds
Segmentation by application
  • Prevention
  • Treatment
  • Other
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Cipla
  • Guilin Pharmaceutical
  • IPCA Laboratories
  • GlaxoSmithKline
  • Mylan Labs
  • Roche
  • Novartis
  • Sanofi Aventis
  • Ajanta Pharma
  • Kunming Pharmaceutical
Key Questions Addressed in this Report

What is the 10-year outlook for the global Malaria Drugs market?

What factors are driving Malaria Drugs market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Malaria Drugs market opportunities vary by end market size?

How does Malaria Drugs break out type, application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Malaria Drugs Annual Sales 2019-2030
  2.1.2 World Current & Future Analysis for Malaria Drugs by Geographic Region, 2019, 2023 & 2030
  2.1.3 World Current & Future Analysis for Malaria Drugs by Country/Region, 2019, 2023 & 2030
2.2 Malaria Drugs Segment by Type
  2.2.1 Aryl Aminoalcohol Compounds
  2.2.2 Antifolate Compounds
  2.2.3 Artemisinin Compounds
2.3 Malaria Drugs Sales by Type
  2.3.1 Global Malaria Drugs Sales Market Share by Type (2019-2024)
  2.3.2 Global Malaria Drugs Revenue and Market Share by Type (2019-2024)
  2.3.3 Global Malaria Drugs Sale Price by Type (2019-2024)
2.4 Malaria Drugs Segment by Application
  2.4.1 Prevention
  2.4.2 Treatment
  2.4.3 Other
2.5 Malaria Drugs Sales by Application
  2.5.1 Global Malaria Drugs Sale Market Share by Application (2019-2024)
  2.5.2 Global Malaria Drugs Revenue and Market Share by Application (2019-2024)
  2.5.3 Global Malaria Drugs Sale Price by Application (2019-2024)

3 GLOBAL MALARIA DRUGS BY COMPANY

3.1 Global Malaria Drugs Breakdown Data by Company
  3.1.1 Global Malaria Drugs Annual Sales by Company (2019-2024)
  3.1.2 Global Malaria Drugs Sales Market Share by Company (2019-2024)
3.2 Global Malaria Drugs Annual Revenue by Company (2019-2024)
  3.2.1 Global Malaria Drugs Revenue by Company (2019-2024)
  3.2.2 Global Malaria Drugs Revenue Market Share by Company (2019-2024)
3.3 Global Malaria Drugs Sale Price by Company
3.4 Key Manufacturers Malaria Drugs Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Malaria Drugs Product Location Distribution
  3.4.2 Players Malaria Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR MALARIA DRUGS BY GEOGRAPHIC REGION

4.1 World Historic Malaria Drugs Market Size by Geographic Region (2019-2024)
  4.1.1 Global Malaria Drugs Annual Sales by Geographic Region (2019-2024)
  4.1.2 Global Malaria Drugs Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Malaria Drugs Market Size by Country/Region (2019-2024)
  4.2.1 Global Malaria Drugs Annual Sales by Country/Region (2019-2024)
  4.2.2 Global Malaria Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Malaria Drugs Sales Growth
4.4 APAC Malaria Drugs Sales Growth
4.5 Europe Malaria Drugs Sales Growth
4.6 Middle East & Africa Malaria Drugs Sales Growth

5 AMERICAS

5.1 Americas Malaria Drugs Sales by Country
  5.1.1 Americas Malaria Drugs Sales by Country (2019-2024)
  5.1.2 Americas Malaria Drugs Revenue by Country (2019-2024)
5.2 Americas Malaria Drugs Sales by Type
5.3 Americas Malaria Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Malaria Drugs Sales by Region
  6.1.1 APAC Malaria Drugs Sales by Region (2019-2024)
  6.1.2 APAC Malaria Drugs Revenue by Region (2019-2024)
6.2 APAC Malaria Drugs Sales by Type
6.3 APAC Malaria Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Malaria Drugs by Country
  7.1.1 Europe Malaria Drugs Sales by Country (2019-2024)
  7.1.2 Europe Malaria Drugs Revenue by Country (2019-2024)
7.2 Europe Malaria Drugs Sales by Type
7.3 Europe Malaria Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Malaria Drugs by Country
  8.1.1 Middle East & Africa Malaria Drugs Sales by Country (2019-2024)
  8.1.2 Middle East & Africa Malaria Drugs Revenue by Country (2019-2024)
8.2 Middle East & Africa Malaria Drugs Sales by Type
8.3 Middle East & Africa Malaria Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Malaria Drugs
10.3 Manufacturing Process Analysis of Malaria Drugs
10.4 Industry Chain Structure of Malaria Drugs

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Malaria Drugs Distributors
11.3 Malaria Drugs Customer

12 WORLD FORECAST REVIEW FOR MALARIA DRUGS BY GEOGRAPHIC REGION

12.1 Global Malaria Drugs Market Size Forecast by Region
  12.1.1 Global Malaria Drugs Forecast by Region (2025-2030)
  12.1.2 Global Malaria Drugs Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Malaria Drugs Forecast by Type
12.7 Global Malaria Drugs Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Cipla
  13.1.1 Cipla Company Information
  13.1.2 Cipla Malaria Drugs Product Portfolios and Specifications
  13.1.3 Cipla Malaria Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.1.4 Cipla Main Business Overview
  13.1.5 Cipla Latest Developments
13.2 Guilin Pharmaceutical
  13.2.1 Guilin Pharmaceutical Company Information
  13.2.2 Guilin Pharmaceutical Malaria Drugs Product Portfolios and Specifications
  13.2.3 Guilin Pharmaceutical Malaria Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.2.4 Guilin Pharmaceutical Main Business Overview
  13.2.5 Guilin Pharmaceutical Latest Developments
13.3 IPCA Laboratories
  13.3.1 IPCA Laboratories Company Information
  13.3.2 IPCA Laboratories Malaria Drugs Product Portfolios and Specifications
  13.3.3 IPCA Laboratories Malaria Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.3.4 IPCA Laboratories Main Business Overview
  13.3.5 IPCA Laboratories Latest Developments
13.4 GlaxoSmithKline
  13.4.1 GlaxoSmithKline Company Information
  13.4.2 GlaxoSmithKline Malaria Drugs Product Portfolios and Specifications
  13.4.3 GlaxoSmithKline Malaria Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.4.4 GlaxoSmithKline Main Business Overview
  13.4.5 GlaxoSmithKline Latest Developments
13.5 Mylan Labs
  13.5.1 Mylan Labs Company Information
  13.5.2 Mylan Labs Malaria Drugs Product Portfolios and Specifications
  13.5.3 Mylan Labs Malaria Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.5.4 Mylan Labs Main Business Overview
  13.5.5 Mylan Labs Latest Developments
13.6 Roche
  13.6.1 Roche Company Information
  13.6.2 Roche Malaria Drugs Product Portfolios and Specifications
  13.6.3 Roche Malaria Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.6.4 Roche Main Business Overview
  13.6.5 Roche Latest Developments
13.7 Novartis
  13.7.1 Novartis Company Information
  13.7.2 Novartis Malaria Drugs Product Portfolios and Specifications
  13.7.3 Novartis Malaria Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.7.4 Novartis Main Business Overview
  13.7.5 Novartis Latest Developments
13.8 Sanofi Aventis
  13.8.1 Sanofi Aventis Company Information
  13.8.2 Sanofi Aventis Malaria Drugs Product Portfolios and Specifications
  13.8.3 Sanofi Aventis Malaria Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.8.4 Sanofi Aventis Main Business Overview
  13.8.5 Sanofi Aventis Latest Developments
13.9 Ajanta Pharma
  13.9.1 Ajanta Pharma Company Information
  13.9.2 Ajanta Pharma Malaria Drugs Product Portfolios and Specifications
  13.9.3 Ajanta Pharma Malaria Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.9.4 Ajanta Pharma Main Business Overview
  13.9.5 Ajanta Pharma Latest Developments
13.10 Kunming Pharmaceutical
  13.10.1 Kunming Pharmaceutical Company Information
  13.10.2 Kunming Pharmaceutical Malaria Drugs Product Portfolios and Specifications
  13.10.3 Kunming Pharmaceutical Malaria Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  13.10.4 Kunming Pharmaceutical Main Business Overview
  13.10.5 Kunming Pharmaceutical Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Malaria Drugs Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Malaria Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Aryl Aminoalcohol Compounds
Table 4. Major Players of Antifolate Compounds
Table 5. Major Players of Artemisinin Compounds
Table 6. Global Malaria Drugs Sales by Type (2019-2024) & (K Units)
Table 7. Global Malaria Drugs Sales Market Share by Type (2019-2024)
Table 8. Global Malaria Drugs Revenue by Type (2019-2024) & ($ million)
Table 9. Global Malaria Drugs Revenue Market Share by Type (2019-2024)
Table 10. Global Malaria Drugs Sale Price by Type (2019-2024) & (USD/Unit)
Table 11. Global Malaria Drugs Sales by Application (2019-2024) & (K Units)
Table 12. Global Malaria Drugs Sales Market Share by Application (2019-2024)
Table 13. Global Malaria Drugs Revenue by Application (2019-2024)
Table 14. Global Malaria Drugs Revenue Market Share by Application (2019-2024)
Table 15. Global Malaria Drugs Sale Price by Application (2019-2024) & (USD/Unit)
Table 16. Global Malaria Drugs Sales by Company (2019-2024) & (K Units)
Table 17. Global Malaria Drugs Sales Market Share by Company (2019-2024)
Table 18. Global Malaria Drugs Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Malaria Drugs Revenue Market Share by Company (2019-2024)
Table 20. Global Malaria Drugs Sale Price by Company (2019-2024) & (USD/Unit)
Table 21. Key Manufacturers Malaria Drugs Producing Area Distribution and Sales Area
Table 22. Players Malaria Drugs Products Offered
Table 23. Malaria Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Malaria Drugs Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Malaria Drugs Sales Market Share Geographic Region (2019-2024)
Table 28. Global Malaria Drugs Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Malaria Drugs Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Malaria Drugs Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Malaria Drugs Sales Market Share by Country/Region (2019-2024)
Table 32. Global Malaria Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Malaria Drugs Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Malaria Drugs Sales by Country (2019-2024) & (K Units)
Table 35. Americas Malaria Drugs Sales Market Share by Country (2019-2024)
Table 36. Americas Malaria Drugs Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Malaria Drugs Revenue Market Share by Country (2019-2024)
Table 38. Americas Malaria Drugs Sales by Type (2019-2024) & (K Units)
Table 39. Americas Malaria Drugs Sales by Application (2019-2024) & (K Units)
Table 40. APAC Malaria Drugs Sales by Region (2019-2024) & (K Units)
Table 41. APAC Malaria Drugs Sales Market Share by Region (2019-2024)
Table 42. APAC Malaria Drugs Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Malaria Drugs Revenue Market Share by Region (2019-2024)
Table 44. APAC Malaria Drugs Sales by Type (2019-2024) & (K Units)
Table 45. APAC Malaria Drugs Sales by Application (2019-2024) & (K Units)
Table 46. Europe Malaria Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Europe Malaria Drugs Sales Market Share by Country (2019-2024)
Table 48. Europe Malaria Drugs Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Malaria Drugs Revenue Market Share by Country (2019-2024)
Table 50. Europe Malaria Drugs Sales by Type (2019-2024) & (K Units)
Table 51. Europe Malaria Drugs Sales by Application (2019-2024) & (K Units)
Table 52. Middle East & Africa Malaria Drugs Sales by Country (2019-2024) & (K Units)
Table 53. Middle East & Africa Malaria Drugs Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Malaria Drugs Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Malaria Drugs Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Malaria Drugs Sales by Type (2019-2024) & (K Units)
Table 57. Middle East & Africa Malaria Drugs Sales by Application (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Malaria Drugs
Table 59. Key Market Challenges & Risks of Malaria Drugs
Table 60. Key Industry Trends of Malaria Drugs
Table 61. Malaria Drugs Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Malaria Drugs Distributors List
Table 64. Malaria Drugs Customer List
Table 65. Global Malaria Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 66. Global Malaria Drugs Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Malaria Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Americas Malaria Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Malaria Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 70. APAC Malaria Drugs Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Malaria Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Europe Malaria Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Malaria Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa Malaria Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Malaria Drugs Sales Forecast by Type (2025-2030) & (K Units)
Table 76. Global Malaria Drugs Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Malaria Drugs Sales Forecast by Application (2025-2030) & (K Units)
Table 78. Global Malaria Drugs Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Cipla Basic Information, Malaria Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Cipla Malaria Drugs Product Portfolios and Specifications
Table 81. Cipla Malaria Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Cipla Main Business
Table 83. Cipla Latest Developments
Table 84. Guilin Pharmaceutical Basic Information, Malaria Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Guilin Pharmaceutical Malaria Drugs Product Portfolios and Specifications
Table 86. Guilin Pharmaceutical Malaria Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Guilin Pharmaceutical Main Business
Table 88. Guilin Pharmaceutical Latest Developments
Table 89. IPCA Laboratories Basic Information, Malaria Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. IPCA Laboratories Malaria Drugs Product Portfolios and Specifications
Table 91. IPCA Laboratories Malaria Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. IPCA Laboratories Main Business
Table 93. IPCA Laboratories Latest Developments
Table 94. GlaxoSmithKline Basic Information, Malaria Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. GlaxoSmithKline Malaria Drugs Product Portfolios and Specifications
Table 96. GlaxoSmithKline Malaria Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. GlaxoSmithKline Main Business
Table 98. GlaxoSmithKline Latest Developments
Table 99. Mylan Labs Basic Information, Malaria Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Mylan Labs Malaria Drugs Product Portfolios and Specifications
Table 101. Mylan Labs Malaria Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Mylan Labs Main Business
Table 103. Mylan Labs Latest Developments
Table 104. Roche Basic Information, Malaria Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Roche Malaria Drugs Product Portfolios and Specifications
Table 106. Roche Malaria Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Roche Main Business
Table 108. Roche Latest Developments
Table 109. Novartis Basic Information, Malaria Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Novartis Malaria Drugs Product Portfolios and Specifications
Table 111. Novartis Malaria Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Novartis Main Business
Table 113. Novartis Latest Developments
Table 114. Sanofi Aventis Basic Information, Malaria Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Sanofi Aventis Malaria Drugs Product Portfolios and Specifications
Table 116. Sanofi Aventis Malaria Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 117. Sanofi Aventis Main Business
Table 118. Sanofi Aventis Latest Developments
Table 119. Ajanta Pharma Basic Information, Malaria Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Ajanta Pharma Malaria Drugs Product Portfolios and Specifications
Table 121. Ajanta Pharma Malaria Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 122. Ajanta Pharma Main Business
Table 123. Ajanta Pharma Latest Developments
Table 124. Kunming Pharmaceutical Basic Information, Malaria Drugs Manufacturing Base, Sales Area and Its Competitors
Table 125. Kunming Pharmaceutical Malaria Drugs Product Portfolios and Specifications
Table 126. Kunming Pharmaceutical Malaria Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 127. Kunming Pharmaceutical Main Business
Table 128. Kunming Pharmaceutical Latest Developments

LIST OF FIGURES

Figure 1. Picture of Malaria Drugs
Figure 2. Malaria Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Malaria Drugs Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Malaria Drugs Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Malaria Drugs Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Aryl Aminoalcohol Compounds
Figure 10. Product Picture of Antifolate Compounds
Figure 11. Product Picture of Artemisinin Compounds
Figure 12. Global Malaria Drugs Sales Market Share by Type in 2023
Figure 13. Global Malaria Drugs Revenue Market Share by Type (2019-2024)
Figure 14. Malaria Drugs Consumed in Prevention
Figure 15. Global Malaria Drugs Market: Prevention (2019-2024) & (K Units)
Figure 16. Malaria Drugs Consumed in Treatment
Figure 17. Global Malaria Drugs Market: Treatment (2019-2024) & (K Units)
Figure 18. Malaria Drugs Consumed in Other
Figure 19. Global Malaria Drugs Market: Other (2019-2024) & (K Units)
Figure 20. Global Malaria Drugs Sales Market Share by Application (2023)
Figure 21. Global Malaria Drugs Revenue Market Share by Application in 2023
Figure 22. Malaria Drugs Sales Market by Company in 2023 (K Units)
Figure 23. Global Malaria Drugs Sales Market Share by Company in 2023
Figure 24. Malaria Drugs Revenue Market by Company in 2023 ($ Million)
Figure 25. Global Malaria Drugs Revenue Market Share by Company in 2023
Figure 26. Global Malaria Drugs Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Malaria Drugs Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Malaria Drugs Sales 2019-2024 (K Units)
Figure 29. Americas Malaria Drugs Revenue 2019-2024 ($ Millions)
Figure 30. APAC Malaria Drugs Sales 2019-2024 (K Units)
Figure 31. APAC Malaria Drugs Revenue 2019-2024 ($ Millions)
Figure 32. Europe Malaria Drugs Sales 2019-2024 (K Units)
Figure 33. Europe Malaria Drugs Revenue 2019-2024 ($ Millions)
Figure 34. Middle East & Africa Malaria Drugs Sales 2019-2024 (K Units)
Figure 35. Middle East & Africa Malaria Drugs Revenue 2019-2024 ($ Millions)
Figure 36. Americas Malaria Drugs Sales Market Share by Country in 2023
Figure 37. Americas Malaria Drugs Revenue Market Share by Country in 2023
Figure 38. Americas Malaria Drugs Sales Market Share by Type (2019-2024)
Figure 39. Americas Malaria Drugs Sales Market Share by Application (2019-2024)
Figure 40. United States Malaria Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 41. Canada Malaria Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 42. Mexico Malaria Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 43. Brazil Malaria Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 44. APAC Malaria Drugs Sales Market Share by Region in 2023
Figure 45. APAC Malaria Drugs Revenue Market Share by Regions in 2023
Figure 46. APAC Malaria Drugs Sales Market Share by Type (2019-2024)
Figure 47. APAC Malaria Drugs Sales Market Share by Application (2019-2024)
Figure 48. China Malaria Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 49. Japan Malaria Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 50. South Korea Malaria Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 51. Southeast Asia Malaria Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 52. India Malaria Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 53. Australia Malaria Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 54. China Taiwan Malaria Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 55. Europe Malaria Drugs Sales Market Share by Country in 2023
Figure 56. Europe Malaria Drugs Revenue Market Share by Country in 2023
Figure 57. Europe Malaria Drugs Sales Market Share by Type (2019-2024)
Figure 58. Europe Malaria Drugs Sales Market Share by Application (2019-2024)
Figure 59. Germany Malaria Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 60. France Malaria Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 61. UK Malaria Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 62. Italy Malaria Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 63. Russia Malaria Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 64. Middle East & Africa Malaria Drugs Sales Market Share by Country in 2023
Figure 65. Middle East & Africa Malaria Drugs Revenue Market Share by Country in 2023
Figure 66. Middle East & Africa Malaria Drugs Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Malaria Drugs Sales Market Share by Application (2019-2024)
Figure 68. Egypt Malaria Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 69. South Africa Malaria Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 70. Israel Malaria Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 71. Turkey Malaria Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 72. GCC Country Malaria Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Malaria Drugs in 2023
Figure 74. Manufacturing Process Analysis of Malaria Drugs
Figure 75. Industry Chain Structure of Malaria Drugs
Figure 76. Channels of Distribution
Figure 77. Global Malaria Drugs Sales Market Forecast by Region (2025-2030)
Figure 78. Global Malaria Drugs Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Malaria Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Malaria Drugs Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Malaria Drugs Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Malaria Drugs Revenue Market Share Forecast by Application (2025-2030)


More Publications